Effects of Phalasarpi and Anuloma-Viloma Pranayama on the maternal and foetal well-being during pregnancy

Two Arm, Randomized, Open Labelled, Comparative Clinical Study to assess the efficacy of Phalasarpi and Anuloma-Viloma Pranayama on the Maternal and Fetal Well Being during Pregnancy - Phalasarpi and Anuloma-Viloma Pranayama on the maternal and foetal well-being during pregnancy

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080520

Enrollment

Registered

2025-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with UPT positive and of age group 21 years to 35 years 2. Patient with UPT positive and confirmed uterine gestation with USG irrespective of their parity28 3. Patient with UPT positive confirmed uterine gestation with USG will be enrolled within 2 months of her LMP 4. UPT positive patient who is willing to consume Phala-Sarpiand performAnuloma-Viloma Pranayama

Exclusion criteria

Exclusion criteria: Patients with Pre-diagnosed underlaying pathology or a systemic disease. 2. Patients not willing to perform Garbhasanskara. 3. Patients with mental disorders like schizophrenia. 4. Patients of younger than 21 years and elder than 40 years of age. 5. Patients with any pre-existing tumour related to reproductive system. 6. Previous 2 LSCS.

Design outcomes

Primary

Measure	Time frame
full term normal vaginal delivery of a baby without any complications Timepoint: Baseline - before 8 weeks with UPT positive and confirmed uterine gestation with USG, 11th or 12th week of gestation, 18th or 19th weeks of gestation, 28th week of gestation, 32nd week of gestation,34th week of gestation,36th week of gestation, on the day of delivery of baby	—

Secondary

Measure	Time frame
Infections, Birth asphyxia and trauma, Preterm births and low birth weight and Congenital malformations and othersTimepoint: Baseline - before 8 weeks with UPT positive and confirmed uterine gestation with USG First follow up 11th or 12th week of gestation Second follow up 18th or 19th weeks of gestation Third follow up - 28th week of gestation Fourth follow up - 32nd week of gestation Fourth follow up 34th week of gestation Sixth follow up - 36th week of gestation last follow up - on the day of delivery of baby	—

Measure

Time frame

Infections, Birth asphyxia and trauma, Preterm births and low birth weight and Congenital malformations and othersTimepoint: Baseline - before 8 weeks with UPT positive and confirmed uterine gestation with USG First follow up 11th or 12th week of gestation Second follow up 18th or 19th weeks of gestation Third follow up - 28th week of gestation Fourth follow up - 32nd week of gestation Fourth follow up 34th week of gestation Sixth follow up - 36th week of gestation last follow up - on the day of delivery of baby

—

Countries

India

Contacts

Public ContactDr Divya Ramugade

D. Y. Patil deemed to be University School of Ayurveda, Nerul, Navi Mumbai

divya.ramugade@dypatil.edu9324446071

Outcome results